The potential role of Kv4.3 K+ channel in heart hypertrophy

Channels

Volumn 8, Issue 3, 2014, Pages 203-209

  Huo, Rong ^a   Sheng, Yue ^a   Guo, Wen Ting ^a   Dong, De Li ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

CaMKII; Heart failure; Heart hypertrophy

Indexed keywords

CALCIUM; SHAL POTASSIUM CHANNEL;

ANIMAL; CARDIOMEGALY; DOG; GENETICS; HEART FAILURE; HUMAN; METABOLISM; MOUSE; RAT;

ANIMALS; CALCIUM; CARDIOMEGALY; DOGS; HEART FAILURE; HUMANS; MICE; RATS; SHAL POTASSIUM CHANNELS;

EID: 84905859892     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.28972     Document Type: Review

References (89)

1. Kääb S, Dixon J, Duc J, Ashen D, Näbauer M, Beuckelmann DJ, Steinbeck G, McKinnon D, Tomaselli GF. Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 1998; 98:1383-93; PMID:9760292; http://dx.doi.org/10.1161/01.CIR.98.14.1383
2. Rossow CF, Minami E, Chase EG, Murry CE, Santana LF. NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction. Circ Res 2004; 94:1340-50; PMID:15087419; http://dx.doi.org/10.1161/01.RES.0000128406. 08418.34
3. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Léger J, Charpentier F, Christ T, Dobrev D, et al. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 2005; 112:471-81; PMID:16027256; http://dx.doi.org/10.1161/CIRCULATIONAHA.104.506857
4. Ji Q, Liu H, Mei Y, Wang X, Feng J, Ding W. Expression changes of ionic channels in early phase of cultured rat atrial myocytes induced by rapid pacing. J Cardiothorac Surg 2013; 8:194; PMID:24074263; http://dx.doi.org/10.1186/1749- 8090-8-194
5. Brundel BJ, Van Gelder IC, Henning RH, Tuinenburg AE, Wietses M, Grandjean JG, Wilde AA, Van Gilst WH, Crijns HJ. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. J Am Coll Cardiol 2001; 37:926-32; PMID:11693772; http://dx.doi.org/ 10.1016/S0735-1097(00)01195-5
6. Qin D, Huang B, Deng L, El-Adawi H, Ganguly K, Sowers JR, El-Sherif N. Downregulation of K(+) channel genes expression in type I diabetic cardiomyopathy. Biochem Biophys Res Commun 2001; 283:549-53; PMID:11341759; http://dx.doi.org/10.1006/bbrc.2001.4825
7. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stühmer W, et al. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 2005; 57:473-508; PMID:16382104; http://dx.doi.org/10.1124/pr.57.4.10
8. Decher N, Uyguner O, Scherer CR, Karaman B, Yüksel-Apak M, Busch AE, Steinmeyer K, Wollnik B. hKChIP2 is a functional modifier of hKv4.3 potassium channels: cloning and expression of a short hKChIP2 splice variant. Cardiovasc Res 2001; 52:255-64; PMID:11684073; http://dx.doi.org/10.1016/S0008-6363(01) 00374-1
9. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KI, Strassle BW, Trimmer JS, et al. Modulation of A-type potassium channels by a family of calcium sensors. Nature 2000; 403:553-6; PMID:10676964; http://dx.doi.org/10.1038/35000592
10. Foeger NC, Wang W, Mellor RL, Nerbonne JM. Stabilization of Kv4 protein by the accessory K+ channel interacting protein 2 (KChIP2) subunit is required for the generation of native myocardial fast transient outward K+ currents. J Physiol 2013; 591:4149-66; PMID:23713033
11. Kuo HC, Cheng CF, Clark RB, Lin JJ, Lin JL, Hoshijima M, Nguyêñ-Trân VT, Gu Y, Ikeda Y, Chu PH, et al. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 2001; 107:801-13; PMID:11747815; http://dx.doi.org/10.1016/S0092-8674(01)00588-8
12. Thomsen MB, Sosunov EA, Anyukhovsky EP, Özgen N, Boyden PA, Rosen MR. Deleting the accessory subunit KChIP2 results in loss of I(to,f) and increased I(K,slow) that maintains normal action potential configuration. Heart Rhythm 2009; 6:370-7; PMID:19251214; http://dx.doi.org/10.1016/j.hrthm.2008.11. 023
13. Dougherty K, Tu L, Deutsch C, Covarrubias M. The dipeptidyl- aminopeptidase-like protein 6 is an integral voltage sensor-interacting β-subunit of neuronal K(V)4.2 channels. Channels (Austin) 2009; 3:122-8; PMID:19372736; http://dx.doi.org/10.4161/chan.3.2.8333
14. Li H-L, Qu Y-J, Lu YC, Bondarenko VE, Wang S, Skerrett IM, Morales MJ. DPP10 is an inactivation modulatory protein of Kv4.3 and Kv1.4. Am J Physiol Cell Physiol 2006; 291:C966-76; PMID:16738002; http://dx.doi.org/10.1152/ ajpcell.00571.2005
15. Radicke S, Cotella D, Graf EM, Ravens U, Wettwer E. Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative β-subunit of human cardiac transient outward current encoded by Kv4.3. J Physiol 2005; 565:751-6; PMID:15890703; http://dx.doi.org/10.1113/jphysiol.2005. 087312
16. El-Haou S, Balse E, Neyroud N, Dilanian G, Gavillet B, Abriel H, Coulombe A, Jeromin A, Hatem SN. Kv4 potassium channels form a tripartite complex with the anchoring protein SAP97 and CaMKII in cardiac myocytes. Circ Res 2009; 104:758-69; PMID:19213956; http://dx.doi.org/10.1161/CIRCRESAHA.108.191007
17. Godreau D, Vranckx R, Maguy A, Rücker-Martin C, Goyenvalle C, Abdelshafy S, Tessier S, Couétil JP, Hatem SN. Expression, regulation and role of the MAGUK protein SAP-97 in human atrial myocardium. Cardiovasc Res 2002; 56:433-42; PMID:12445884; http://dx.doi.org/10.1016/S0008-6363(02)00602-8
18. Yang E-K, Alvira MR, Levitan ES, Takimoto K. Kvbeta subunits increase expression of Kv4.3 channels by interacting with their C termini. J Biol Chem 2001; 276:4839-44; PMID:11087728; http://dx.doi.org/10.1074/jbc.M004768200
19. Deschênes I, Tomaselli GF. Modulation of Kv4.3 current by accessory subunits. FEBS Lett 2002; 528:183-8; PMID:12297301; http://dx.doi.org/10.1016/ S0014-5793(02)03296-9
20. Yang EK, Alvira MR, Levitan ES, Takimoto K. Kvbeta subunits increase expression of Kv4.3 channels by interacting with their C termini. J Biol Chem 2001; 276:4839-44; PMID:11087728; http://dx.doi.org/10.1074/jbc.M004768200
21. Wang L, Takimoto K, Levitan ES. Differential association of the auxiliary subunit Kvbeta2 with Kv1.4 and Kv4.3 K+ channels. FEBS Lett 2003; 547:162-4; PMID:12860406; http://dx.doi.org/10.1016/S0014-5793(03)00705-1
22. Kuryshev YA, Gudz TI, Brown AM, Wible BA. KChAP as a chaperone for specific K(+) channels. Am J Physiol Cell Physiol 2000; 278:C931-41; PMID:10794667
23. Wible BA, Yang Q, Kuryshev YA, Accili EA, Brown AM. Cloning and expression of a novel K+ channel regulatory protein, KChAP. J Biol Chem 1998; 273:11745-51; PMID:9565597; http://dx.doi.org/10.1074/jbc.273.19.11745
24. Lundby A, Olesen S-P. KCNE3 is an inhibitory subunit of the Kv4.3 potassium channel. Biochem Biophys Res Commun 2006; 346:958-67; PMID:16782062; http://dx.doi.org/10.1016/j.bbrc.2006.06.004
25. Grammer JB, Bosch RF, Kühlkamp V, Seipel L. Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation. J Cardiovasc Electrophysiol 2000; 11:626-33; PMID:10868735; http://dx.doi.org/10.1111/j.1540- 8167.2000.tb00024.x
26. Xiao L, Coutu P, Villeneuve LR, Tadevosyan A, Maguy A, Le Bouter S, Allen BG, Nattel S. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes. Circ Res 2008; 103:733-42; PMID:18723449; http://dx.doi.org/10.1161/CIRCRESAHA.108.171157
27. Akar FG, Wu RC, Juang GJ, Tian Y, Burysek M, Disilvestre D, Xiong W, Armoundas AA, Tomaselli GF. Molecular mechanisms underlying K+ current downregulation in canine tachycardia-induced heart failure. Am J Physiol Heart Circ Physiol 2005; 288:H2887-96; PMID:15681701; http://dx.doi.org/10.1152/ ajpheart.00320.2004
28. Ferrer T, Arín RM, Casis E, Torres-Jacome J, Sanchez-Chapula JA, Casis O. Mechanisms responsible for the altered cardiac repolarization dispersion in experimental hypothyroidism. Acta Physiol (Oxf) 2012; 204:502-12; PMID:21933354; http://dx.doi.org/10.1111/j.1748-1716.2011.02364.x
29. Dartsch T, Fischer R, Gapelyuk A, Weiergraeber M, Ladage D, Schneider T, Schirdewan A, Reuter H, Mueller-Ehmsen J, Zobel C. Aldosterone induces electrical remodeling independent of hypertension. Int J Cardiol 2013; 164:170-8; PMID:21764470; http://dx.doi.org/10.1016/j.ijcard.2011.06.100
30. Wu C-T, Qi X-Y, Huang H, Naud P, Dawson K, Yeh Y-H, Harada M, Kuo C-T, Nattel S. Disease and region-related cardiac fibroblast potassium current variations and potential functional significance. Cardiovasc Res 2014; PMID:24596399; http://dx.doi.org/10.1093/cvr/cvu055
31. Zhang T-T, Takimoto K, Stewart AF, Zhu C, Levitan ES. Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine. Circ Res 2001; 88:476-82; PMID:11249870; http://dx.doi.org/10. 1161/01.RES.88.5.476
32. Zhou C, Ziegler C, Birder LA, Stewart AF, Levitan ES. Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA. Circ Res 2006; 98:1040-7; PMID:16556864; http://dx.doi.org/10.1161/01.RES.0000218989. 52072.e7
33. Sun B, Sheng Y, Huo R, Hu CW, Lu J, Li SL, Liu X, Wang YC, Dong DL. Bone morphogenetic protein-4 contributes to the down-regulation of Kv4.3 K+ channels in pathological cardiac hypertrophy. Biochem Biophys Res Commun 2013; 436:591-4; PMID:23747723; http://dx.doi.org/10.1016/j.bbrc.2013.05.113
34. Liu W, Deng J, Xu J, Wang H, Yuan M, Liu N, Jiang Y, Liu J. High-mobility group box 1 (HMGB1) downregulates cardiac transient outward potassium current (Ito) through downregulation of Kv4.2 and Kv4.3 channel transcripts and proteins. J Mol Cell Cardiol 2010; 49:438-48; PMID:20483361; http://dx.doi.org/10.1016/j.yjmcc.2010.05.004
35. Jia Y, Takimoto K. Mitogen-activated protein kinases control cardiac KChIP2 gene expression. Circ Res 2006; 98:386-93; PMID:16385079; http://dx.doi.org/10.1161/01.RES.0000201956.86258.e1
36. Wang Y, Cheng J, Chen G, Rob F, Naseem RH, Nguyen L, Johnstone JL, Hill JA. Remodeling of outward K+ currents in pressure-overload heart failure. J Cardiovasc Electrophysiol 2007; 18:869-75; PMID:17537202; http://dx.doi.org/10. 1111/j.1540-8167.2007.00864.x
37. Suzuki T, Shioya T, Murayama T, Sugihara M, Odagiri F, Nakazato Y, Nishizawa H, Chugun A, Sakurai T, Daida H, et al. Multistep ion channel remodeling and lethal arrhythmia precede heart failure in a mouse model of inherited dilated cardiomyopathy. PLoS One 2012; 7:e35353; PMID:22514734; http://dx.doi.org/10.1371/journal.pone.0035353
38. Grubb S, Speerschneider T, Occhipinti D, Fiset C. OLESEN SP, THOMSEN MB, CALLOE K. Loss of K+ Currents in Heart Failure Is Accentuated in KChIP2 Deficient Mice. J Cardiovasc Electrophysiol 2014; http://dx.doi.org/10.1111/jce. 12422
39. Xiao L, Koopmann TT, Ördög B, Postema PG, Verkerk AO, Iyer V, Sampson KJ, Boink GJJ, Mamarbachi MA, Varro A, et al. Unique cardiac Purkinje fiber transient outward current β-subunit composition: a potential molecular link to idiopathic ventricular fibrillation. Circ Res 2013; 112:1310-22; PMID:23532596; http://dx.doi.org/10.1161/CIRCRESAHA.112.300227
40. Giudicessi JR, Ye D, Tester DJ, Crotti L, Mugione A, Nesterenko VV, Albertson RM, Antzelevitch C, Schwartz PJ, Ackerman MJ. Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm 2011; 8:1024-32; PMID:21349352; http://dx.doi.org/10.1016/j.hrthm.2011.02.021
41. Olesen MS, Refsgaard L, Holst AG, Larsen AP, Grubb S, Haunsø S, Svendsen JH, Olesen S-P, Schmitt N, Calloe K. A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation. Cardiovasc Res 2013; 98:488-95; PMID:23400760; http://dx.doi.org/10.1093/cvr/ cvt028
42. Giudicessi JR, Ye D, Kritzberger CJ, Nesterenko VV, Tester DJ, Antzelevitch C, Ackerman MJ. Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death. Hum Mutat 2012; 33:989-97; PMID:22457051; http://dx.doi.org/10.1002/humu.22058
43. Dixon JE, Shi W, Wang H-S, McDonald C, Yu H, Wymore RS, Cohen IS, McKinnon D. Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current. Circ Res 1996; 79:659-68; PMID:8831489; http://dx.doi.org/10.1161/01.RES.79.4.659
44. Varró A, Lathrop DA, Hester SB, Nánási PP, Papp JG. Ionic currents and action potentials in rabbit, rat, and guinea pig ventricular myocytes. Basic Res Cardiol 1993; 88:93-102; PMID:8389123
45. Liu HB, Yang BF, Dong DL. Calcineurin and electrical remodeling in pathologic cardiac hypertrophy. Trends Cardiovasc Med 2010; 20:148-53; PMID:21742270; http://dx.doi.org/10.1016/j.tcm.2010.12.003
46. Capuano V, Ruchon Y, Antoine S, Sant MC, Renaud JF. Ventricular hypertrophy induced by mineralocorticoid treatment or aortic stenosis differentially regulates the expression of cardiac K+ channels in the rat. Mol Cell Biochem 2002; 237:1-10; PMID:12236575; http://dx.doi.org/10.1023/A: 1016518920693
47. Lee J-K, Nishiyama A, Kambe F, Seo H, Takeuchi S, Kamiya K, Kodama I, Toyama J. Downregulation of voltage-gated K(+) channels in rat heart with right ventricular hypertrophy. Am J Physiol 1999; 277:H1725-31; PMID:10564125
48. Zhang TT, Takimoto K, Stewart AF, Zhu C, Levitan ES. Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine. Circ Res 2001; 88:476-82; PMID:11249870; http://dx.doi.org/10. 1161/01.RES.88.5.476
49. Tsuji Y, Zicha S, Qi XY, Kodama I, Nattel S. Potassium channel subunit remodeling in rabbits exposed to long-term bradycardia or tachycardia: discrete arrhythmogenic consequences related to differential delayed-rectifier changes. Circulation 2006; 113:345-55; PMID:16432066; http://dx.doi.org/10.1161/ CIRCULATIONAHA.105.552968
50. Huang B, Qin D, El-Sherif N. Early downregulation of K+ channel genes and currents in the postinfarction heart. J Cardiovasc Electrophysiol 2000; 11:1252-61; PMID:11083246; http://dx.doi.org/10.1046/j.1540-8167.2000.01252.x
51. Qin D, Huang B, Deng L, El-Adawi H, Ganguly K, Sowers JR, El-Sherif N. Downregulation of K(+) channel genes expression in type I diabetic cardiomyopathy. Biochem Biophys Res Commun 2001; 283:549-53; PMID:11341759; http://dx.doi.org/10.1006/bbrc.2001.4825
52. Kassiri Z, Zobel C, Nguyen TT, Molkentin JD, Backx PH. Reduction of I(to) causes hypertrophy in neonatal rat ventricular myocytes. Circ Res 2002; 90:578-85; PMID:11909822; http://dx.doi.org/10.1161/01.RES.0000012223.86441.A1
53. Gao L, Li Y, Schultz HD, Wang W-Z, Wang W, Finch M, Smith LM, Zucker IH. Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure. Am J Physiol Heart Circ Physiol 2010; 298:H945-55; PMID:20044444; http://dx.doi.org/10.1152/ajpheart. 00145.2009
54. Lebeche D, Kaprielian R, del Monte F, Tomaselli G, Gwathmey JK, Schwartz A, Hajjar RJ. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation 2004; 110:3435-43; PMID:15557376; http://dx.doi.org/10.1161/01.CIR.0000148176.33730.3F
55. Lebeche D, Kaprielian R, Hajjar R. Modulation of action potential duration on myocyte hypertrophic pathways. J Mol Cell Cardiol 2006; 40:725-35; PMID:16600293; http://dx.doi.org/10.1016/j.yjmcc.2006.01.018
56. Kaprielian R, Wickenden AD, Kassiri Z, Parker TG, Liu PP, Backx PH. Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction. J Physiol 1999; 517:229-45; PMID:10226162; http://dx.doi.org/10.1111/j.1469-7793.1999.0229z.x
57. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93:215-28; PMID:9568714; http://dx.doi.org/10.1016/ S0092-8674(00)81573-1
58. Dong D, Duan Y, Guo J, Roach DE, Swirp SL, Wang L, Lees-Miller JP, Sheldon RS, Molkentin JD, Duff HJ. Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K+ channels. Cardiovasc Res 2003; 57:320-32; PMID:12566105; http://dx.doi.org/10.1016/S0008- 6363(02)00661-2
59. Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, McKinsey TA. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 2004; 24:8374-85; PMID:15367659; http://dx.doi.org/10.1128/MCB.24.19.8374-8385.2004
60. Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 1997; 386:855-8; PMID:9126747; http://dx.doi.org/10.1038/386855a0
61. Akar FG, Wu RC, Juang GJ, Tian Y, Burysek M, Disilvestre D, Xiong W, Armoundas AA, Tomaselli GF. Molecular mechanisms underlying K+ current downregulation in canine tachycardia-induced heart failure. Am J Physiol Heart Circ Physiol 2005; 288:H2887-96; PMID:15681701; http://dx.doi.org/10.1152/ ajpheart.00320.2004
62. Xiao L, Coutu P, Villeneuve LR, Tadevosyan A, Maguy A, Le Bouter S, Allen BG, Nattel S. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes. Circ Res 2008; 103:733-42; PMID:18723449; http://dx.doi.org/10.1161/CIRCRESAHA.108.171157
63. Maguy A, Le Bouter S, Comtois P, Chartier D, Villeneuve L, Wakili R, Nishida K, Nattel S. Ion channel subunit expression changes in cardiac Purkinje fibers: a potential role in conduction abnormalities associated with congestive heart failure. Circ Res 2009; 104:1113-22; PMID:19359601; http://dx.doi.org/10. 1161/CIRCRESAHA.108.191809
64. Yue L, Melnyk P, Gaspo R, Wang Z, Nattel S. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 1999; 84:776-84; PMID:10205145; http://dx.doi.org/10.1161/01.RES.84.7.776
65. Zicha S, Xiao L, Stafford S, Cha TJ, Han W, Varro A, Nattel S. Transmural expression of transient outward potassium current subunits in normal and failing canine and human hearts. J Physiol 2004; 561:735-48; PMID:15498806; http://dx.doi.org/10.1113/jphysiol.2004.075861
66. Borlak J, Thum T. Hallmarks of ion channel gene expression in end-stage heart failure. FASEB J 2003; 17:1592-608; PMID:12958166; http://dx.doi.org/10. 1096/fj.02-0889com
67. Greenstein JL, Wu R, Po S, Tomaselli GF, Winslow RL. Role of the calcium-independent transient outward current I(to1) in shaping action potential morphology and duration. Circ Res 2000; 87:1026-33; PMID:11090548; http://dx.doi.org/10.1161/01.RES.87.11.1026
68. Frank-Hansen R, Larsen LA, Andersen P, Jespersgaard C, Christiansen M. Mutations in the genes KCND2 and KCND3 encoding the ion channels Kv4.2 and Kv4.3, conducting the cardiac fast transient outward current (ITO,f), are not a frequent cause of long QT syndrome. Clin Chim Acta 2005; 351:95-100; PMID:15563876; http://dx.doi.org/10.1016/j.cccn.2004.08.017
69. Dong M, Sun X, Prinz AA, Wang HS. Effect of simulated I(to) on guinea pig and canine ventricular action potential morphology. Am J Physiol Heart Circ Physiol 2006; 291:H631-7; PMID:16565319; http://dx.doi.org/10.1152/ajpheart. 00084.2006
70. Keskanokwong T, Lim HJ, Zhang P, Cheng J, Xu L, Lai D, Wang Y. Dynamic Kv4.3-CaMKII unit in heart: an intrinsic negative regulator for CaMKII activation. Eur Heart J 2011; 32:305-15; PMID:21148163; http://dx.doi.org/10. 1093/eurheartj/ehq469
71. Li Q, Zhang Y, Sheng Y, Huo R, Sun B, Teng X, Li N, Zhu JX, Yang BF, Dong DL. Large T-antigen up-regulates Kv4.3 K+ channels through Sp1, and Kv4.3 K+ channels contribute to cell apoptosis and necrosis through activation of calcium/calmodulin-dependent protein kinase II. Biochem J 2012; 441:859-67; PMID:22023388; http://dx.doi.org/10.1042/BJ20111604
72. Zhang T, Brown JH. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res 2004; 63:476-86; PMID:15276473; http://dx.doi.org/10.1016/j.cardiores.2004.04.026
73. Zhang R, Khoo MS, Wu Y, Yang Y, Grueter CE, Ni G, Price EE Jr., Thiel W, Guatimosim S, Song LS, et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 2005; 11:409-17; PMID:15793582; http://dx.doi.org/10.1038/nm1215
74. Dobrev D, Wehrens XH. Calmodulin kinase II, sarcoplasmic reticulum Ca2+ leak, and atrial fibrillation. Trends Cardiovasc Med 2010; 20:30-4; PMID:20685575; http://dx.doi.org/10.1016/j.tcm.2010.03.004
75. El-Haou S, Balse E, Neyroud N, Dilanian G, Gavillet B, Abriel H, Coulombe A, Jeromin A, Hatem SN. Kv4 potassium channels form a tripartite complex with the anchoring protein SAP97 and CaMKII in cardiac myocytes. Circ Res 2009; 104:758-69; PMID:19213956; http://dx.doi.org/10.1161/CIRCRESAHA.108.191007
76. Anderson ME, Brown JH, Bers DM. CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 2011; 51:468-73; PMID:21276796; http://dx.doi.org/10.1016/j.yjmcc.2011.01.012
77. Hudmon A, Schulman H, Kim J, Maltez JM, Tsien RW, Pitt GS. CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation. J Cell Biol 2005; 171:537-47; PMID:16275756; http://dx.doi.org/10.1083/jcb.200505155
78. Bers DM, Grandi E. Calcium/calmodulin-dependent kinase II regulation of cardiac ion channels. J Cardiovasc Pharmacol 2009; 54:180-7; PMID:19333131; http://dx.doi.org/10.1097/FJC.0b013e3181a25078
79. Wang Y, Tandan S, Cheng J, Yang C, Nguyen L, Sugianto J, Johnstone JL, Sun Y, Hill JA. Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure. J Biol Chem 2008; 283:25524-32; PMID:18622016; http://dx.doi.org/10.1074/jbc.M803043200
80. Wagner S, Dybkova N, Rasenack EC, Jacobshagen C, Fabritz L, Kirchhof P, Maier SK, Zhang T, Hasenfuss G, Brown JH, et al. Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J Clin Invest 2006; 116:3127-38; PMID:17124532; http://dx.doi.org/10.1172/JCI26620
81. Anderson ME. Pathways for CaMKII activation in disease. Heart Rhythm 2011; 8:1501-3; PMID:21699838; http://dx.doi.org/10.1016/j.hrthm.2011.04.027
82. Said M, Becerra R, Valverde CA, Kaetzel MA, Dedman JR, Mundiña-Weilenmann C, Wehrens XH, Vittone L, Mattiazzi A. Calcium-calmodulin dependent protein kinase II (CaMKII): a main signal responsible for early reperfusion arrhythmias. J Mol Cell Cardiol 2011; 51:936-44; PMID:21888910; http://dx.doi.org/10.1016/j.yjmcc.2011.08.010
83. Macías A, Moreno C, Moral-Sanz J, Cogolludo A, David M, Alemanni M, Pérez-Vizcaíno F, Zaza A, Valenzuela C, González T. Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials. J Mol Cell Cardiol 2010; 49:984-92; PMID:20858500; http://dx.doi.org/10.1016/j.yjmcc.2010.09.012
84. Wang H, Shi H, Zhang L, Pourrier M, Yang B, Nattel S, Wang Z. Nicotine is a potent blocker of the cardiac A-type K(+) channels. Effects on cloned Kv4.3 channels and native transient outward current. Circulation 2000; 102:1165-71; PMID:10973847; http://dx.doi.org/10.1161/01.CIR.102.10.1165
85. Caballero R, Gómez R, Núñez L, Moreno I, Tamargo J, Delpón E. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations. Cardiovasc Res 2004; 64:457-66; PMID:15537499; http://dx.doi.org/10.1016/j.cardiores.2004.07.022
86. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M; Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005; 352:1071-80; PMID:15713944; http://dx.doi.org/10.1056/NEJMoa050405
87. Ishikawa K, Nakai S, Takenaka T, Kanamasa K, Hama J, Ogawa I, Yamamoto T, Oyaizu M, Kimura A, Yamamoto K, et al.; Secondary Prevention Group. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Circulation 1997; 95:2368-73; PMID:9170398; http://dx.doi.org/10.1161/01.CIR.95.10.2368
88. El Gebeily G, Fiset C. Upregulation of ventricular potassium channels by chronic tamoxifen treatment. Cardiovasc Res 2011; 90:68-76; http://dx.doi.org/ 10.1093/cvr/cvq384; PMID:21131637
89. Grainger DJ, Schofield PM. Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence. Circulation 2005; 112:3018-24; PMID:16275887